B
Benchling provides an AI platform for biotech R&D that helps scientists design experiments, manage data, and automate workflows.
LatchBio
LatchBio builds verifiable benchmarks and platforms for deploying and evaluating frontier AI agents on real-world biological data across domains like spatial biology, single-cell analysis, and biosecurity.
LatchBio develops infrastructure for evaluating and deploying artificial intelligence in biological research. The company builds verifiable benchmarks that assess how frontier AI agents perform on complex, real-world biological data. Its work spans several technical domains, including spatial biology, single-cell analysis, epigenomics, preclinical pharmacology, and biosecurity.
The firm operates three main platforms. benchmarks.bio is a venue for publishing reproducible benchmark research. agent.bio enables the deployment of frontier AI agents into live scientific workflows. Latch Biosecurity, formed after the acquisition of TwentyTwo, focuses on benchmarks, audits, and red-teaming to evaluate whether AI models meaningfully raise biological risks.
LatchBio's platforms support over 40 solution providers and more than 300 biopharmas and R&D labs worldwide through public interactive sandboxes. The company is headquartered in San Francisco, California.
Open jobs
No open jobs right now.